Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma
Clinical trial NCT05461794 · TERMINATED
Trial details
- NCT number
- NCT05461794
- Sponsor
- BeiGene
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-03
- Primary completion
- 2024-02-26
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.